REFERENCES
- Neville B. W., Day T. A. Oral cancer and precancerous lesions. CA Cancer J. Clin. 2002; 52(4)195–215
- Jemal A., Clegg L. X., Ward E., Ries L. A., Wu X., et al. Annual report to the nation on the status of cancer, 1975-2001, with a special feature regarding survival. Cancer 2004; 101(1)3–27
- Walker D. M., Boey G., McDonald L. A. The pathology of oral cancer. Pathology 2003; 35(5)376–383
- Meek D. W. The p53 response to DNA damage. DNA Repair (Amst.) 2004; 3(8–9)1049–1056
- Thomas S., Brennan J., Martel G., Frazer I., Montesano R., Sidransky D., Hollstein M. Mutations in the conserved regions of p53 are infrequent in betel-associated oral cancers from Papua New Guinea. Cancer Res. 1994; 54(13)3588–3593
- Prives C., Manfredi J. J. The continuing saga of p53—more sleepless nights ahead. Mol. Cell 2005; 19(6)719–721
- Bourdon J. C., Fernandes K., Murray-Zmijewski F., Liu G., Diot A., et al. p53 isoforms can regulate p53 transcriptional activity. Genes Dev. 2005; 19(18)2122–2137
- Rohaly G., Chemnitz J., Dehde S., Nunez A. M., Heukeshoven J., Deppert W., Dornreiter I. A novel human p53 isoform is an essential element of the ATR-intra-S phase checkpoint. Cell 2005; 122(1)21–32
- Kaghad M., Bonnet H., Yang A., Creancier L., Biscan J. C., et al. Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell 1997; 90(4)809–819
- Yang A., Kaghad M., Wang Y., Gillett E., Fleming M. D., Dotsch V., Andrews N. C., Caput D., McKeon F. p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol Cell 198; 2(3)305–316
- Little N. A., Jochemsen A. G. p63. Int J Biochem Cell Biol 2002; 34(1)6–9
- Moll U. M., Slade N. p63 and p73: roles in development and tumor formation. Mol Cancer Res 2004; 2(7)371–386
- Westfall M. D., Pietenpol J. A. p63: Molecular complexity in development and cancer. Carcinogenesis 2004; 25(6)857–864
- Benard J., Douc-Rasy S., Ahomadegbe J. C. TP53 family members and human cancers. Hum Mutat 2003; 21(3)182–191
- Matheny K. E., Barbieri C. E., Sniezek J. C., Arteaga C. L., Pietenpol J. A. Inhibition of epidermal growth factor receptor signaling decreases p63 expression in head and neck squamous carcinoma cells. Laryngoscope 2003; 113(6)936–939
- Ord R. A., Blanchaert R. H., Jr. Current management of oral cancer. A multidisciplinary approach. J Am Dent Assoc 2001; 132: 19S–23S, (Suppl.)
- Pindborg J. J., Reichart P. A., Smith C. J., van der Wall I. Histological typing of cancer and precancer of the oral mucosa. Springer-Verlag, Berlin 1997
- Cancer I. U.A. TNM classification of malignant tumours. Wiley & Sons Ltd., New York 2002
- Lo Muzio L., Staibano S., Pannone G., Bucci P., Nocini P. F., Bucci E., De Rosa G. Expression of cell cycle and apoptosis-related proteins in sporadic odontogenic keratocysts and odontogenic keratocysts associated with the nevoid basal cell carcinoma syndrome. J Dent Res 1999; 78(7)1345–1353
- Chen Y. K., Hsue S. S., Lin L. M. Expression of p63 protein and mRNA in oral epithelial dysplasia. J Oral Pathol Med 2005; 34(4)232–239
- Foschini M. P., Gaiba A., Cocchi R., Pennesi M. G., Gatto M. R., Frezza G. P., Pession A. Pattern of p63 expression in squamous cell carcinoma of the oral cavity. Virchows Arch 2004; 444: 332–339
- Thurfjell N., Coates P. J., Uusitalo T., Mahani D., Dabelsteen E., Dahlqvist A., Sjostrom B., Roos G., Nylander K. Complex p63 mRNA isoform expression patterns in squamous cell carcinoma of the head and neck. Int J Oncol 2004; 25(1)27–35
- Sniezek J. C., Matheny K. E., Westfall M. D., Pietenpol J. A. Dominant negative p63 isoform expression in head and neck squamous cell carcinoma. Laryngoscope 2004; 114(12)2063–2072
- Thurfjell N., Coates P. J., Boldrup L., Lindgren B., Backlund B., Uusitalo T., Mahani D., Dabelsteen E., Dahlqvist A., Sjostrom B., Roos G., Vojtesek B., Nenutil R., Nylander K. Function and importance of p63 in normal oral mucosa and squamous cell carcinoma of the head and neck. Adv Otorhinolaryngol 2005; 62: 49–57
- Bortoluzzi M. C., Yurgel L. S., Dekker N. P., Jordan R. C., Regezi J. A. Assessment of p63 expression in oral squamous cell carcinomas and dysplasias. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004; 98(6)698–704